AbbVie (ABBV) Current Deferred Tax Assets (2012 - 2015)

AbbVie (ABBV) has reported Current Deferred Tax Assets for 4 consecutive years, with $1.1 billion the latest figure, recorded in Q3 2015.

• On a quarterly basis, Current Deferred Tax Assets rose 109.92% year-over-year to $1.1 billion in Q3 2015; TTM through Sep 2015 was $1.1 billion, a 109.92% increase from a year earlier, with the FY2014 full-year figure at $896.0 million, up 16.97% from the prior year.
• Current Deferred Tax Assets was $1.1 billion for Q3 2015 at AbbVie, down from $1.2 billion in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $1.4 billion in Q2 2013 and troughed at $524.0 million in Q3 2014.
• A 4-year average of $1.1 billion and a median of $1.1 billion in 2014 frame the typical range for Current Deferred Tax Assets.
• Across the five-year window, Current Deferred Tax Assets tumbled 63.07% in 2014 and surged 109.92% in 2015, its largest moves.
• Over 4 years, Current Deferred Tax Assets stood at $669.0 million in 2012, then grew by 14.5% to $766.0 million in 2013, then climbed by 16.97% to $896.0 million in 2014, then increased by 22.77% to $1.1 billion in 2015.
• The last three Current Deferred Tax Assets figures came in at $1.1 billion (Q3 2015), $1.2 billion (Q2 2015), and $1.1 billion (Q1 2015), per Business Quant data.